Fixed 1:5 molar ratio of daunorubicin and cytarabine has been shown to produce a synergistic effect in vitro3
Liposomes accumulate and persist in the bone marrow in high concentrations, as shown in animal models4
Synergistic molar ratio maintained for a prolonged period of time – over 24 hours after administration1,4
Vyxeos Liposomal is preferentially taken up by leukaemia cells vs normal bone marrow cells, as shown in vitro2,4
Important notice: This site has been created for healthcare professionals only. By entering this site, you are confirming that you are a European healthcare professional. This site contains promotional information.
I CONFIRM THAT I AM A EUROPEAN HEALTHCARE PROFESSIONAL
I AM A UK HEALTHCARE PROFESSIONAL
I AM A US HEALTHCARE PROFESSIONAL
I AM NOT A HEALTHCARE PROFESSIONAL
Please note that this information is intended for healthcare professionals in the UK
Please note that this information is intended for healthcare professionals in the US only
For more information:
By clicking here you will be taken to the European Medicines Agency’s external website
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly through your national medicines side effect reporting system or to Jazz Pharmaceuticals AEreporting@jazzpharma.com. By reporting side effects, you can help provide more information on the safety of this medicine.